Publications by authors named "Shu-ichi Ueda"

Claim this Profile
R
Restoration of albumin production by nucleoside analogue therapy in patients with chronic hepatitis B.
Mineko Shibayama, Jesus Serrano-Luna, Tetsuro Sohda, Motoko Kawashima, Eri Yamauchi, Shu-Ichi Ueda

Med Mol Morphol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinoma.
Daisuke Morihara, Kaoru Iwata, Takayuki Hanano, Hideo Kunimoto, Shizuka Kuno, Shu-Ichi Ueda

Hepatol Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: proposal of a three (times) × 3 (years) index.
Keiji Yokoyama, Akira Anan, Kaoru Iwata, Shinya Nishizawa, Daisuke Morihara, Shu-ichi Ueda

J Gastroenterol Hepatol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporally distinct expression of vesicular glutamate transporters 1 and 2 during embryonic development of the rat olfactory system.
Hideki Ohmomo, Ayuka Ehara, Sachine Yoshida, Fumihiro Shutoh, Shu-ichi Ueda

Neurosci Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of Wilson disease: Analysis of 10 cases.
Yasuaki Takeyama, Keiji Yokoyama, Kazuhide Takata, Takashi Tanaka, Kunitoshi Sakurai, Shu-Ichi Ueda

Hepatol Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis.
Yasuaki Takeyama, Kazuko Kanegae, Shinjiro Inomata, Kazuhide Takata, Takashi Tanaka, Shu-Ichi Ueda

Med Mol Morphol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative transporter pathways in patients with untreated early-stage and late-stage primary biliary cirrhosis.
Yasuaki Takeyama, Yuko Uehara, Shinjiro Inomata, Daisuke Morihara, Shinya Nishizawa, Shu-ichi Ueda

Liver Int· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budd-Chiari syndrome: two cases with different courses.
Shinjiro Inomata, Yasuaki Takeyama, Takashi Tanaka, Shu-Ichi Ueda, Daisuke Morihara

Case Rep Gastroenterol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib.
Shu-Ichi Ueda, Yuji Basaki, Masumi Yoshie, Katsuhiro Ogawa, Shotaro Sakisaka

Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.
Shintaro Nakao, Takashi Kuwano, Chikako Tsutsumi-Miyahara, Shu-ichi Ueda, Yusuke N Kimura

J Clin Invest· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells.
Akira Hirata, Fumihito Hosoi, Miho Miyagawa, Shu-ichi Ueda, Seiji Naito

Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Mayumi Ono, Akira Hirata, Takuro Kometani, Miho Miyagawa, Shu-ichi Ueda

Mol Cancer Ther· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis